WO2008130319A3 - Nouveaux composés 805 - Google Patents
Nouveaux composés 805 Download PDFInfo
- Publication number
- WO2008130319A3 WO2008130319A3 PCT/SE2008/050458 SE2008050458W WO2008130319A3 WO 2008130319 A3 WO2008130319 A3 WO 2008130319A3 SE 2008050458 W SE2008050458 W SE 2008050458W WO 2008130319 A3 WO2008130319 A3 WO 2008130319A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tetrahydronaphtalene
- chromane
- pain
- novel
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/54—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne de nouveaux composés et une composition pharmaceutique contenant ces composés et l'utilisation desdits composés en thérapie. Cette invention porte également sur des procédés de préparation de ces composés et sur de nouveaux intermédiaires utiles dans la préparation de ces derniers.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91330907P | 2007-04-23 | 2007-04-23 | |
US60/913,309 | 2007-04-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008130319A2 WO2008130319A2 (fr) | 2008-10-30 |
WO2008130319A3 true WO2008130319A3 (fr) | 2008-12-18 |
Family
ID=39876086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2008/050458 WO2008130319A2 (fr) | 2007-04-23 | 2008-04-22 | Nouveaux composés 805 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008130319A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120122924A1 (en) * | 2010-11-15 | 2012-05-17 | Abbott Laboratories | Nampt inhibitors |
JP6117104B2 (ja) | 2010-11-15 | 2017-04-19 | アッヴィ・インコーポレイテッド | Namptおよびrock阻害薬 |
WO2015006280A1 (fr) * | 2013-07-10 | 2015-01-15 | Vertex Pharmaceuticals Incorporated | Amides de pipéridine fusionnés utiles en tant que modulateurs de canaux ioniques |
WO2020054657A1 (fr) | 2018-09-10 | 2020-03-19 | 科研製薬株式会社 | Dérivé d'amide hétéroaromatique et médicament le contenant |
CN112062688B (zh) * | 2020-09-28 | 2023-02-03 | 绍兴兴欣新材料股份有限公司 | 一种n,n-二乙基乙酰胺的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997034883A1 (fr) * | 1996-03-22 | 1997-09-25 | Astra Aktiebolag | Derives de 1,2,3,4-tetrahydronaphthalene substitues |
WO1999005134A1 (fr) * | 1997-07-25 | 1999-02-04 | Astra Aktiebolag | Derives de 1,2,3,4-tetrahydronaphthalene substitue |
WO1999014212A1 (fr) * | 1997-09-18 | 1999-03-25 | Astrazeneca Ab | Derives de chromane substitues |
WO1999014213A1 (fr) * | 1997-09-18 | 1999-03-25 | Astrazeneca Ab | Derives de chromane substitue |
WO2005013914A2 (fr) * | 2003-08-08 | 2005-02-17 | Vertex Pharmaceuticals Incorporated | Compositions utilisees comme inhibiteurs de canaux sodium voltage dependants |
US20060025415A1 (en) * | 2003-08-08 | 2006-02-02 | Gonzalez Jesus E Iii | Compositions useful as inhibitors of voltage-gated sodium channels |
-
2008
- 2008-04-22 WO PCT/SE2008/050458 patent/WO2008130319A2/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997034883A1 (fr) * | 1996-03-22 | 1997-09-25 | Astra Aktiebolag | Derives de 1,2,3,4-tetrahydronaphthalene substitues |
WO1999005134A1 (fr) * | 1997-07-25 | 1999-02-04 | Astra Aktiebolag | Derives de 1,2,3,4-tetrahydronaphthalene substitue |
WO1999014212A1 (fr) * | 1997-09-18 | 1999-03-25 | Astrazeneca Ab | Derives de chromane substitues |
WO1999014213A1 (fr) * | 1997-09-18 | 1999-03-25 | Astrazeneca Ab | Derives de chromane substitue |
WO2005013914A2 (fr) * | 2003-08-08 | 2005-02-17 | Vertex Pharmaceuticals Incorporated | Compositions utilisees comme inhibiteurs de canaux sodium voltage dependants |
US20050137190A1 (en) * | 2003-08-08 | 2005-06-23 | Gonzalez Jesus E.Iii | Compositions useful as inhibitors of voltage-gated sodium channels |
US20060025415A1 (en) * | 2003-08-08 | 2006-02-02 | Gonzalez Jesus E Iii | Compositions useful as inhibitors of voltage-gated sodium channels |
Also Published As
Publication number | Publication date |
---|---|
WO2008130319A2 (fr) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008130320A3 (fr) | Nouveaux composés 806 | |
TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
GB0522311D0 (en) | Pharmaceutical compositions for the treatment of pain | |
MY179527A (en) | Catecholamine derivatives useful for the treatment of parkinson's disease | |
HK1166983A1 (zh) | 包含用於治療疾病或紊亂的化合物的固體形式,其組合物,及其用途 | |
MY161991A (en) | Proteasome inhibitors | |
WO2009153496A3 (fr) | Composes agonistes ppar, preparation et utilisations pour le traitement du diabete et/ou des dyslipidemies | |
TW200606162A (en) | Pyrazolopyridine derivatives | |
WO2007038459A3 (fr) | Composes de carboxyamine et leurs methodes d'utilisation | |
TW200745122A (en) | New compounds I | |
IL201189A (en) | Fluorization derivatifrone derivatives used as iron pellets in the treatment of neurodegenerative diseases, their preparation and their pharmaceutical preparations | |
WO2008076954A3 (fr) | Composés hétérocycliques et procédés d'utilisation de ceux-ci | |
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
WO2009062576A8 (fr) | Nouveaux dérivés de benzimidazole-dihydrothiadiazinone en tant que des inhibiteurs de la fructose-1,6-bisphosphatase, et compositions pharmaceutiques les comprenant | |
IL192415A0 (en) | Pharmaceutical composition for the treatment of nail diseases | |
WO2009099553A3 (fr) | Utilisation d’inhibiteur de kinase pour le traitement de l’athérosclérose | |
MX2013002118A (es) | 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
CL2008000982A1 (es) | Compuestos derivados de 5-oxo-isoxazol-carboxamida; proceso de preparacion; composicion farmaceutica; procedimiento de produccion de la composicion farmaceutica; y uso en el tratamiento y/o prevencion de trastornos ateroscleroticos, de metabolismo de | |
IL195632A0 (en) | Substituted carboxamides | |
WO2008130319A3 (fr) | Nouveaux composés 805 | |
TW200745133A (en) | New compounds II | |
WO2007139833A3 (fr) | Composés d'imidazo-azéphinone | |
MX2013002119A (es) | Sustituidas-2-oxo- y 2-tioxo-dihidroquinolin-3-carboxamidas como moduladores de kcnq2/3. | |
WO2008130321A3 (fr) | Nouveaux composés 807 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08779259 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08779259 Country of ref document: EP Kind code of ref document: A2 |